Cite
HARVARD Citation
Beg, M. et al. (2017). Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. Journal of surgical oncology. 116 (1), pp. 83-88. [Online].